Evidence map›Paper›PMID 36676276›Full record

ArticleMaterials (Basel, Switzerland)2023

Smart PEG-Block-PLA/PLA Nanosystems: Impact of the Characteristics of the Polymer Blend on the Redox Responsiveness.

Louise Van Gheluwe, Stephanie David, Eric Buchy, Igor Chourpa, Emilie Munnier

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Louise Van GheluweEA 6295 Nanomédicaments et Nanosondes, Université de Tours, Faculté de Pharmacie, 31 Avenue Monge, 37200 Tours, France.
Stephanie DavidEA 6295 Nanomédicaments et Nanosondes, Université de Tours, Faculté de Pharmacie, 31 Avenue Monge, 37200 Tours, France.
Eric BuchyLaboratoires Eriger, 33 rue Augustin Fresnel, 37170 Chambray les Tours, France.
Igor ChourpaEA 6295 Nanomédicaments et Nanosondes, Université de Tours, Faculté de Pharmacie, 31 Avenue Monge, 37200 Tours, France.
Emilie MunnierEA 6295 Nanomédicaments et Nanosondes, Université de Tours, Faculté de Pharmacie, 31 Avenue Monge, 37200 Tours, France.ORCID 0000-0002-6691-4484

Funding

Conseil Régional Centre Val de Loire MISTIC 2017-00118114FEDER EX003257
6 · The paper itself

Abstract

Nanocarriers (NCs) were designed from three polymer blends (B1, B2 and B3) and investigated as smart drug delivery systems (SDDS). The blends are composed of a "smart" copolymer, where methoxy poly(ethylene glycol) and poly(lactic acid) are connected via a redox-responsive disulfide bond (mPEG-SS-PLA), and of a "conventional" polymer, poly(lactic acid) (PLA). They differ by mPEG-SS-PLA/PLA ratio and PLA molecular weight. Nanoprecipitation was used to prepare NCs. Three concentrations were tested, and fluorescent dye Nile red (NR) was used as a model payload. The results show that the characteristics of the NCs, such as size and drug release kinetics, are influenced by the type of blend and the concentration used during the nanoprecipitation process. The more redox-responsive blend was B2 (ratio 1:3, PLA 5 kDa) at 16 mg/mL: the quantity of NR released was tripled upon 24 h of incubation in a reducing medium. This study reveals that the amount of disulfide bonds present in a NC is not the only parameter to be considered to design an SDDS. The stability of the SDDS in a presumably non-stimulating environment is also important to limit uncontrolled release during storage or in the body before the biological target is reached.

Indexed as

mPEG-SS-PLA/PLA blendredox-responsive disulfide bondsmart drug delivery system (SDDS)triggered release

Identifiers

PMID36676276
PMCPMC9864163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.